| 国際シンポジウム1 |
| IS1 |
4月21日（金） 9:00～11:45 A会場 |
 |
Gene therapy 20 years later:
Does is still hold promise for pediatric diseases?
Past, present and future of gene therapy for childhood illnesses |
|
Moderators |
Fabio Candotti |
(Genetics and Molecular Biology Branch, National Human Genome Research
Institute, National Institutes of Health, USA) |
|
|
Tadashi Ariga |
(Department of Pediatrics, Hokkaido University Graduate School of Medicine) |
|
|
|
|
| IS1-1 |
Introduction to the symposium of gene therapy for childhood illnesses |
|
|
Tadashi Ariga |
(Department of Pediatrics, Hokkaido University Graduate School of Medicine) |
|
|
|
|
| IS1-2 |
Gene therapy for severe combined immunodeficiency: advances and drawbacks |
|
|
Fabio Candotti |
(Genetics and Molecular Biology Branch, National Human Genome Research
Institute, National Institutes of Health, USA) |
|
|
|
|
| IS1-3 |
Successful gene therapy for ADA deficiency in Japan |
|
|
Makoto Otsu |
(Department of Clinical and Experimental Medicine, University of Tsukuba) |
|
|
|
|
| IS1-4 |
What we have learned from X-SCID gene therapy and future perspective |
|
|
Satoru Kumaki |
(Department of Pediatric Oncology, Institute of Development, Aging and
Cancer, Tohoku University) |
|
|
|
|
| IS1-5 |
Perspectives on Gene Therapy for Chronic Granulomatous Disease |
|
|
Hiroyuki Nunoi |
(Department of Pediatrics, Miyazaki Medical College, University of Miyazaki) |
|
|
|
|
| IS1-6 |
Gene and Cell Therapy for Relapsed Leukemia after Allogeneic Stem Cell
Transplantation |
|
|
Masafumi Onodera |
(Gene and Cell Therapy Group, Major of Medical Sciences, Graduate School
of Comprehensive Human Sciences, University of Tsukuba) |
|
|
|
|
| IS1-7 |
Recent advance and future goals of gene therapy for hereditary neurological
and metabolic diseases |
|
|
Torayuki Okumura |
(Department of Clinical Genetics and Molecular Medicine, National Center
for Child Health and Development) |
|
|
|
|
| 国際シンポジウム2 |
| IS2 |
4月21日（金） 14:30～17:00 A会場 |
|
Emerging and reemerging infections in children |
|
Moderators |
Toshio Miyawaki |
(Department of Pediatrics, Toyama University) |
|
|
Hiroyuki Moriuchi |
(Department of Pediatrics, Nagasaki University) |
|
|
|
|
| IS2-1 |
14:30～14:55 |
|
Genetic susceptibility and immune evasion in SARS and avian influenza |
|
|
Yu-lung LAU |
(Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital,
The University of Hong Kong, Hong Kong) |
|
|
|
|
| IS2-2 |
14:55～15:20 |
|
Role of clinical research in prevention and control of emerging diseases:
SARS and avian influenza |
|
|
Hitoshi Oshitani |
(Department of Virology, Tohoku University, Graduate School of Medicine) |
|
|
|
|
| IS2-3 |
15:20～15:45 |
|
Dengue: clinical features and an immune mechanism of thrombocytopenia |
|
|
Kazunori Oishi |
(Department of Special Pathogens, International Research Center, Institute
for Microbial Diseases, Osaka University) |
|
|
|
|
| IS2-4 |
15:45～16:10 |
|
Preliminary Study on human metapneumovirus infections in infants and young
children with acute respiratory infections in Beijing, China |
|
|
Yuan QIAN |
(Capital Institute of Pediatrics in Beijing) |
|
|
|
|
| IS2-5 |
16.10～16:35 |
|
Genetic Bases and Epidemiology of Mendelian Susceptibility to Mycobacterial
Infection in Japan |
|
|
Hidetoshi Takada |
(Department of Pediatrics, Graduate School of Medical Sciences, Kyushu
University) |
|
|
|
|
| IS2-6 |
16.35～17:00 |
|
Regulation of Cytokine Dynamics during Human Tuberculosis: the Role of
Mitogen-activated Protein Kinase Pathways |
|
|
Eun-Kyeong Jo |
(Dept. of Microbiology, College of Medicine, Chungnam National University) |
|
|
 |
|
| 国際シンポジウム3 |
| IS3 |
4月22日（土） 9:00～11:45 B会場 |
|
Can pulmonary hypertension be cured? Lessons learned from bench and bedside. |
|
Moderators |
M. Rabinovitch |
(Stanford University School of Medicine) |
|
|
Yoshihide Mitani |
(Department of Pediatrics, Mie University Graduate School of Medicine) |
|
|
|
|
| IS3-1 |
Intersecting Pathways Converge in Inducing Pulmonary Vascular Disease:
Implications for Reversing Advanced Pathology |
|
|
M. Rabinovitch |
(Stanford University School of Medicine) |
|
|
|
|
| IS3-2 |
Pediatric PAH Patients In Japan―Genetic Backgrounds and Treatment Update― |
|
|
Tsutomu Saji |
(Department of Pediatrics, Toho University Medical Center, Omori Hospital) |
|
|
|
|
| IS3-3 |
Living-Donor Lobar Lung Transplantation for Pediatric Patients with Primary
Pulmonary Hypertension |
|
|
Hiroshi Date |
(Department of Cancer and Thoracic Surgery, Okayama University Graduate
School) |
|
|
|
|
| IS3-4 |
Clinical Features in Patients with Idiopathic Pulmonary Arterial Hypertension
or Familial Pulmonary Arterial Hypertension who have TGF-β Receptor Genes
Mutations |
|
|
Norifumi Nakanishi |
(Division of Cardiology, Department of Medicine, National Cardiovascular
Center Osaka, Japan) |
|
|
|
|
| IS3-5 |
Roles of TGF-β superfamily signaling in the development of pulmonary hypertension |
|
|
Kohei Miyazono |
(Department of Molecular Pathology, Graduate School of Medicine, University
of Tokyo) |
|
|
|
|
| IS3-6 |
Osteopontin could be a novel target for the treatment of pulmonary arterial
hypertension |
|
|
Yasushi Hoshikawa |
(Department of Thoracic Surgery, Institute of Development, Aging, and Cancer,
Tohoku University) |
|
|
|
|
| IS3-7 |
Roles of vascular inflammation and bone marrow-derived stem cells in the
pathogenesis of pulmonary hypertension: Pulmonary endothelial function
revisited |
|
|
Yoshihide Mitani |
(Department of Pediatrics, Mie University Graduate School of Medicine) |
|
|
|
|
